Antibacterial Agents TRIZ Cases

Amphiphilic molecules template mesoporous metal oxide structures, achieving 30-40% drug loading and diffusion-driven release.

Engineered camelid antibodies bind flagellar proteins to reduce bacterial colonization while resisting gastrointestinal proteases.

Replacing toxic organic solvents with diethylene glycol monoethyl ether creates a rifaximin tau solvate that maintains stability and improves bioavailability.

Chromatography at low pH selectively binds inter-alpha inhibitor proteins, resolving the trade-off between purification complexity and protein reliability.

5-Alkynyl pyrimidines inhibit PI3Kα and mTOR pathways to treat proliferative disorders while minimizing off-target toxicity.

Custom linkers with specific amino acid compositions resolve affinity-selectivity trade-offs for precise gene editing across variable base pair gaps.

Tetrazole beta-lactamase inhibitors overcome CTX-M resistance by forming specific polar contacts that enhance binding affinity.

A defined bacterial composition reduces VRE colonization by converting primary bile acids to secondary bile acids, mitigating antibiotic resistance risks.

DNase enzymes degrade extracellular DNA matrices to expose embedded bacteria, enabling effective antibiotic treatment and immune system access.

Thiazole derivatives inhibit TBK1 and IKKε kinases, addressing the lack of effective inhibitors for cancer and inflammatory diseases.

A single-phase oil-based foamable carrier uses a glyceride surfactant to form thermally stable foams.

Fermented Lactobacillus secretion reduces microbial loads by 80% while eliminating skin irritation from synthetic alcohols.

Sterile casein-derived phosphopeptide solutions reduce dry period length and mastitis risk while increasing post-parturition milk yield.

Segmented vectors with separated cutting sites and homology arms resolve the precision-flexibility trade-off in Cas-based genome editing.

Segmented air mixing prevents premature clotting and clogging while ensuring complete fibrinogen-thrombin interaction for reliable wound sealing.

Recombinant BCG vaccine overexpresses Mycobacterium tuberculosis antigens and up-regulates the DosR regulon to prevent latent infection reactivation.

Synthesizing deuterated morpholine derivatives via acid-catalyzed reaction of Formula II compounds to achieve high isotopic enrichment.

A dual-layer oral colon-targeted delivery system uses pH-sensitive and bacterial flora-sensitive layers to protect active ingredients during transit.

Fusion inhibitor peptides block HIV entry without triggering inflammatory side effects from full cytokine therapies.

Short peptide inhibitors block PD-1/PD-L1 interaction to resolve the trade-off between immune stability and response efficacy.

Tat protein therapy eliminates persistent viral reservoirs to restore immune responses, overcoming the limitations of standard HAART treatments.

A star polypeptide uses segmented N-carboxyanhydride polymerization to build defined core and radiating arms for precise molecular architecture.

Targeting TORC2 boosts survival against Burkholderia cepacia by promoting host tolerance rather than reducing bacterial load.

Segmented UPPS binding sites enable targeted inhibitor design that restores methicillin sensitivity against resistant Staphylococcus aureus strains.

Sialylated oligosaccharides act as decoys to prevent H. pylori attachment, reducing antibiotic reliance and resistance.

Optimized CDR regions in humanized IL-17A antibodies resolve therapeutic gaps in rheumatoid arthritis by improving binding affinity and neutralization.

Crystalline form A of tigecycline hydrochloride exhibits high water solubility and stability through controlled salt formation processes.

A stable antimicrobial catheter lock solution uses pH adjustment to 6-8 alongside EDTA and alcohol.

Formula I compounds inhibit deubiquitinases with high selectivity, reducing toxicity while improving solubility.

Amphipathic lytic peptides disrupt biofilm integrity to treat infections resistant to conventional antimicrobial agents.

Modified coiled coil proteins fuse polyarginine sequences to enhance binding affinity for negatively charged polymers and nucleic acids.

A prime-boost vaccination protocol uses an mRNA construct to induce a robust immune response in subjects.

Basic solution hydrolyzes eggshell membrane proteins, resolving low yield and high cost trade-offs in commercial protein production.

Poly(aryl ether ketone) polymers functionalized with metal sulfonate groups deliver bactericidal activity against pathogens like Staphylococcus aureus.

Formula I compounds inhibit leukotriene A4 hydrolase to reduce pro-inflammatory leukotriene B4 production in autoimmune disorders.

Targeting Akt3 bioavailability modulates regulatory T cell function to balance immune suppression and anti-tumor immunity.

Engineered B cell cultures enable sensitive T cell epitope recognition, eliminating frequent dendritic cell isolation and reducing background noise.

Hydroxyapatite chromatography removes detergent contamination during hydrophobic protein extraction, improving yield and reducing industrial processing costs.

In situ polymerization creates a durable barrier that reduces mastitis risk while allowing antimicrobial delivery.

Targeted amino acid deletions in the SEB toxin reduce T-cell receptor binding to prevent toxic shock syndrome.

N-acetylcysteine disrupts biofilms to treat multidrug-resistant Burkholderia cepacia complex infections.

Peracid wound dressings resolve cytotoxicity trade-offs by delivering broad-spectrum antimicrobial activity without harming healthy cells.

Oxadiazole diaryl compounds resolve selectivity trade-offs by acting as selective S1P1 receptor agonists to improve tolerability in autoimmune treatments.

Tellurium nanowire templates enable rapid noble metal nanoparticle growth, addressing toxicity concerns in antimicrobial treatments.

Halogenated cyclic peptides selectively destroy multidrug-resistant bacteria while sparing normal gut flora.

Host-directed BCL-2 and MCL-1 inhibitors overcome antimicrobial resistance by inducing apoptosis in granulomas, reducing treatment duration.

Casein and chitosan microparticles encapsulate probiotic bacteria to maintain viability during acidic gastrointestinal transit.